ClearPoint Neuro, Inc.

NASDAQ (USD): ClearPoint Neuro, Inc. (CLPT)

Last Price

18.42

Today's Change

+3.38 (22.47%)

Day's Change

15.99 - 19.00

Trading Volume

731,274

Profile
CLPT

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Joseph Michael Burnett Mr. Joseph Michael Burnett

Full Time Employees:  107 107

IPO Date:  2012-05-22 2012-05-22

CIK:  0001285550 0001285550

ISIN:  US18507C1036 US18507C1036

CUSIP:  18507C103 18507C103

Beta:  1.11 1.11

Last Dividend:  0.00 0.00

Dcf Diff:  36.12 36.12

Dcf:  -17.70 -17.70

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Address

120 S. Sierra Avenue,
Solana Beach, CA 92075, US

888 287 9109

http://www.clearpointneuro.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment